XTL Biopharmaceuticals Ltd. (XTLB)
$1.92-3.03%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5M
- Beta
- 0.45
- P/E (TTM)
- -0.90
- Short % float
- 0.26%
- Days to cover
- 1.3
- SI change
- -15.6%
- 1W
- -11.93%
- 1M
- -25.00%
- vs SPY 1W
- -12.35%
- vs SPY 1M
- -27.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on XTLB?
- LOPJLB’s latest quantitative signal on XTL Biopharmaceuticals Ltd. (XTLB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is XTLB in?
- XTL Biopharmaceuticals Ltd. (XTLB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does XTL Biopharmaceuticals Ltd. (XTLB) do?
- XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome. The company holds a crucial licensing agreement with Yeda Research and Development Company Limite…